KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Net Margin (2016 - 2026)

Fulgent Genetics' Net Margin history spans 11 years, with the latest figure at 34.9% for Q1 2026.

  • On a quarterly basis, Net Margin fell 1920.0% to 34.9% in Q1 2026 year-over-year; TTM through Mar 2026 was 31.09%, a 1715.0% decrease, with the full-year FY2025 number at 18.75%, down 369.0% from a year prior.
  • Net Margin hit 34.9% in Q1 2026 for Fulgent Genetics, up from 5854.5% in the prior quarter.
  • Over the last five years, Net Margin for FLGT hit a ceiling of 47.95% in Q1 2022 and a floor of 5854.5% in Q4 2025.
  • Historically, Net Margin has averaged 386.02% across 5 years, with a median of 16.12% in 2025.
  • Biggest five-year swings in Net Margin: soared 17403bps in 2024 and later crashed -584677bps in 2025.
  • Tracing FLGT's Net Margin over 5 years: stood at 1.27% in 2022, then crashed by -14399bps to 181.76% in 2023, then surged by 96bps to 7.73% in 2024, then tumbled by -75680bps to 5854.5% in 2025, then soared by 99bps to 34.9% in 2026.
  • Business Quant data shows Net Margin for FLGT at 34.9% in Q1 2026, 5854.5% in Q4 2025, and 7.86% in Q3 2025.